Advertisement

Wiener klinische Wochenschrift

, Volume 131, Issue 13–14, pp 349–350 | Cite as

MUW researcher of the month

MUW researcher of the month
  • 4 Downloads

Notes

Literatur

  1. 1.
    Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.CrossRefGoogle Scholar
  2. 2.
    Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113(18):2238–44.CrossRefGoogle Scholar
  3. 3.
    Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875–83.CrossRefGoogle Scholar
  4. 4.
    Suri RM, Vanoverschelde JL, Grigioni F, et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA. 2013;310(6):609–16.CrossRefGoogle Scholar
  5. 5.
    Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–e185.CrossRefGoogle Scholar
  6. 6.
    Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91.CrossRefGoogle Scholar
  7. 7.
    Zilberszac R, Heinze G, Binder T, Laufer G, Gabriel H, Rosenhek R. Long-Term Outcome of Active Surveillance in Severe But Asymptomatic Primary Mitral Regurgitation. Jacc Cardiovasc Imaging. 2018;11(9):1213–21.CrossRefGoogle Scholar
  8. 8.
    Zilberszac R, Gleiss A, Binder T, et al. Prognostic relevance of mitral and tricuspid regurgitation in patients with severe aortic stenosis. Eur Heart J Cardiovasc Imaging. 2018;19(9):985–92.  https://doi.org/10.1093/ehjci/jey027 . CrossRefPubMedGoogle Scholar
  9. 9.
    Zilberszac R, Gabriel H, Schemper M, Laufer G, Maurer G, Rosenhek R. Asymptomatic Severe Aortic Stenosis in the Elderly. Jacc Cardiovasc Imaging. 2017;10(1):43–50.CrossRefGoogle Scholar
  10. 10.
    Zilberszac R, Lancellotti P, Gilon D, et al. Role of a heart valve clinic programme in the management of patients with aortic stenosis. Eur Heart J Cardiovasc Imaging. 2017;18(2):138–144.  https://doi.org/10.1093/ehjci/jew133 . CrossRefPubMedGoogle Scholar
  11. 11.
    Zilberszac R, Gabriel H, Schemper M, et al. Outcome of combined stenotic and regurgitant aortic valve disease. J Am Coll Cardiol. 2013;61(14):1489–95.CrossRefGoogle Scholar
  12. 12.
    Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation. 2010;121(1):151–6.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Personalised recommendations